Parent company Quarterhill is still undergoing a strategic review to determine whether to sell WiLAN, but doesn’t want the delay to remind anyone of the stagnant BlackBerry patent sale
The company has scrapped its failed $600 million deal with Catapult IP Innovations and now will seek US and Canadian government regulatory approval to close a $200 million pact
Like many others, the bank held thousands of patents as security for loan deals, but almost certainly had no idea of their value – or lack of it
The Canadian company has secured another three years’ worth of income from an encumbered portfolio, while the buyers can take high-quality assets into new markets
03 February 2022
The billion-dollar-plus agreement shows the astronomical financial value that individual pharmaceutical patents can have
03 February 2022
Transaction represents the first publicly recorded US patent deal for small lab focused on VVC
03 February 2022
New entity can now begin monetising a horde of around 35,000 assets that is already licensed to many major players in the mobile space
31 January 2022
Spate of recent transactions show the value of gene-editing patents beyond Cas9
28 January 2022
After so many delays in finalising the transaction, the pressure is on the Canadian company to get it over the line
27 January 2022
The Anglo-Swedish company has been a trailblazer in the monetisation of deprioritised IP
21 January 2022
Recent moves by MediaTek, Asus and Acer all show that IP owners are seeking to boost returns
20 January 2022
A 'bear trap' in China, ongoing US validity woes and big M&A opportunities around established brands and IP are among trends highlighted by practitioners
17 January 2022
A spate of pharma-high tech innovation partnerships have dominated opening days of the year
11 January 2022
Unlock unlimited access to all IAM content
